Investors

Invest in Biostage and help bring our products to the patients who need them

Download our IR presentation

Stock Information

OTCQBBSTG

Press Releases

Mar 1, 2023

Biostage Announces Chairman and CEO Transition

Existing Board member Jerry He to replace David Green as Chairman and Chief Executive Officer; David Green to remain on the Board and support transition HOLLISTON, Mass., March 1, 2023 /PRNewswire/ --

Jan 12, 2023

Biostage Amends CEO Employment Agreement

Biostage removes Interim qualification from Mr. Green's title, making him Chief Executive Officer. HOLLISTON, Mass., Jan. 12, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the...

Dec 28, 2022

Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer

IQVIA was selected because of its dedicated gastrointestinal team and depth of experience in running cell-therapy clinical trials. HOLLISTON, Mass., Dec. 28, 2022 /PRNewswire/ -- Biostage, Inc....

More >

Events

Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update

Tuesday, November 12, 2019

9:00am - 10:00am EST

Biostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business Update

Tuesday, August 13, 2019

9:00am - 10:00am EDT

Biostage to Host Conference Call to Discuss First Quarter 2019 Financial Results and Business Update

Tuesday, May 14, 2019

9:00am - 10:00am EDT

Biostage, Inc.
84 October Hill Road
Suite 11
Holliston, Massachusetts 01746
United States